Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
- DOI
- 10.1016/j.annonc.2022.10.001
- Published
- 2022 Dec
- Container
- Annals of oncology : official journal of the European Society for Medical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2022.10.001,
title = {Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.},
author = {Haanen J and Obeid M and Spain L and Carbonnel F and Wang Y and Robert C and Lyon AR and Wick W and Kostine M and Peters S and Jordan K and Larkin J and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org},
year = {2022},
journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
doi = {10.1016/j.annonc.2022.10.001},
url = {https://doi.org/10.1016/j.annonc.2022.10.001}
}RIS
TY - JOUR TI - Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. AU - Haanen J AU - Obeid M AU - Spain L AU - Carbonnel F AU - Wang Y AU - Robert C AU - Lyon AR AU - Wick W AU - Kostine M AU - Peters S AU - Jordan K AU - Larkin J AU - ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org PY - 2022 JO - Annals of oncology : official journal of the European Society for Medical Oncology DO - 10.1016/j.annonc.2022.10.001 UR - https://doi.org/10.1016/j.annonc.2022.10.001 ER -
APA
J, H., M, O., L, S., F, C., Y, W., C, R., AR, L., W, W., M, K., S, P., K, J., J, L., & clinicalguidelines@esmo.org, E. G. C. E. A. (2022). Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2022.10.001
Source records
- pubmed · retrieved 2026-09-25T20:05:03.552Z